Recently, positron emission tomography with prostate-specific membrane antigen (PSMA PET) has gained importance in the setting of PCa initial staging, especially because of its known high sensitivity and specificity for metastasis (Hofman et al. 2020). The gene discussed is FOLH1; the disease is posterior cortical atrophy.